At a glance
The September 14, 2020, Clinical Laboratory COVID-19 Response (CLCR) call included updates on the interim final rule from CMS, technical guidance for implementation of laboratory data reporting, and laboratory data reporting for COVID-19, as well as an FDA update.
Agenda
Archived LOCS Materials Access
Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
CMS Update on Interim Final Rule – Laboratory Reporting: Regina Van Brakle and Amy Zale, Centers for Medicare & Medicaid Services (CMS)
Technical Guidance for Implementation of Laboratory Data Reporting: Mike Waters, Testing and Diagnostics Task Force, U.S. Department of Health and Human Services (HHS)
Laboratory Data Reporting for COVID-19 – A Clinical Laboratory Experience: Jordan Olson, Geisinger Health System, Department of Laboratory Medicine
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.